OxiWear Announces Medicare and Insurance Coverage Expansion for Continuous Oxygen Measuring Device

▤ Summary

OxiWear now has Medicare and participating insurance coverage for its continuous oxygen measuring device. This expansion should make the FDA-cleared wearable more accessible to patients with chronic respiratory, cardiovascular, and related hypoxia conditions. The company positions the coverage milestone as a key step toward reducing reimbursement barriers and improving affordability. The device provides continuous blood oxygen monitoring and low-oxygen alerts in both clinical and home settings. The announcement highlights a broader push to improve patient safety, outcomes, and care access.

▦ Linked Companies